Edesa Biotech Transmettre P/E
Quel est le Transmettre P/E de Edesa Biotech?
Le Transmettre P/E de Edesa Biotech, Inc. est 0.17
Quelle est la définition de Transmettre P/E?
Le ratio prix à terme/bénéfice est le rapport entre le prix des actions d'une société et son bénéfice par action estimé pour les douze prochains mois.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Transmettre P/E des entreprises dans Health Care secteur sur NASDAQ par rapport à Edesa Biotech
Que fait Edesa Biotech?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Entreprises avec transmettre p/e similaire à Edesa Biotech
- Lekoil a Transmettre P/E de 0.14
- Mediclinic International plc a Transmettre P/E de 0.14
- Sintex Industries a Transmettre P/E de 0.15
- Dewan Housing Finance a Transmettre P/E de 0.15
- Young & Co.'s Brewery Plc a Transmettre P/E de 0.17
- Sumeet Industries a Transmettre P/E de 0.17
- Edesa Biotech a Transmettre P/E de 0.17
- Nichols Plc a Transmettre P/E de 0.17
- Vertex Inc a Transmettre P/E de 0.18
- Quantum Genomics SA a Transmettre P/E de 0.18
- Dewan Housing Finance a Transmettre P/E de 0.18
- Churchill China Plc a Transmettre P/E de 0.18
- Kwality a Transmettre P/E de 0.19